Paper · 32073014
Glycyrrhizin inhibits osteoarthritis development through suppressing the PI3K/AKT/NF-κB signaling pathway in vivo and in vitro.
Jiang RH and 6 others. Food Funct, 2020. Cited by 40 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Glycyrrhizin inhibits osteoarthritis development through suppressing the PI3K/AKT/NF-κB signaling pathway in vivo and in vitro. Papers, record 32073014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32073014
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Glycyrrhizin inhibits osteoarthritis development through suppressing the PI3K/AKT/NF-κB signaling pathway in vivo and in vitro.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chondrocytes | Major topic |
| Glycyrrhizic Acid | Major topic |
| NF-kappa B | Major topic |
| Phosphatidylinositol 3-Kinases | Major topic |
| Proto-Oncogene Proteins c-akt | Major topic |
| Animals | |
| Cells, Cultured | |
| Cytokines | |
| Gene Expression Regulation | |
| Humans | |
| Interleukin-1beta | |
| Male | |
| Mice | |
| Molecular Structure | |
| Nitric Oxide | |
| Phosphorylation | |
| Signal Transduction |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,885,282 | Glycyrrhizic acid attenuates corneal inflammation and pathological angiogenesis through FAK/PI3K/AKT signaling. | Mol Med Rep | 2026 | https://conductscience.org/library/papers/42885282 | PubMed |
| 42,582,610 | Oyster hydrolysate attenuates osteoarthritis progression by modulating inflammatory signaling and extracellular matrix homeostasis. | Nutr Res Pract | 2026 | https://conductscience.org/library/papers/42582610 | PubMed |
| 42,371,378 | Bioactive compounds of Glycyrrhiza glabra and their functional role in modulating gut inflammation and intestinal homeostasis. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/42371378 | PubMed |
| 41,789,596 | Mechanisms and therapeutic potential of glycyrrhizic acid: Insights into key signaling pathways and disease modulation (Review). | Mol Med Rep | 2026 | https://conductscience.org/library/papers/41789596 | PubMed |
| 41,705,157 | Mechanistic insights into non-coding RNAs regulate autophagy in chondrocytes and their contribution to osteoarthritis. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/41705157 | PubMed |
| 41,463,300 | Emerging Role of Calycosin in Inflammatory Diseases: Molecular Mechanisms and Potential Therapeutic Applications. | Biomolecules | 2025 | https://conductscience.org/library/papers/41463300 | PubMed |
| 40,137,300 | Investigating the Mechanism of Action of Ipomoea pes-caprae in the Treatment of Rheumatoid Arthritis Based on Serum Metabolomics and Network Pharmacology. | Mar Drugs | 2025 | https://conductscience.org/library/papers/40137300 | PubMed |
| 40,012,623 | The dual anti-inflammatory and anticoagulant effects of Jianpi Huashi Tongluo prescription on Rheumatoid Arthritis through inhibiting the activation of the PI3K/AKT signaling pathway. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40012623 | PubMed |
| 39,606,009 | Understanding the impact of diabetes on bone health: A clinical review. | Metabol Open | 2024 | https://conductscience.org/library/papers/39606009 | PubMed |
| 39,376,558 | Regulating the lncRNA DSCR9/RPLP2/PI3K/AKT axis: an important mechanism of Xinfeng capsules in improving rheumatoid arthritis. | Front Immunol | 2024 | https://conductscience.org/library/papers/39376558 | PubMed |
1 to 10 of 25
See all 25 cited byGenes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACAN | 176 | PubTator's text mining | https://conductscience.org/library/genes/176 | NCBI Gene |
| ADAMTS5 | 11,096 | PubTator's text mining | https://conductscience.org/library/genes/11096 | NCBI Gene |
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| IL1B | 3,553 | PubTator's text mining | https://conductscience.org/library/genes/3553 | NCBI Gene |
| IL6 | 3,569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| MMP13 | 4,322 | PubTator's text mining | https://conductscience.org/library/genes/4322 | NCBI Gene |
| MMP3 | 4,314 | PubTator's text mining | https://conductscience.org/library/genes/4314 | NCBI Gene |
| NFKB1 | 4,790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| NOS2 | 4,843 | PubTator's text mining | https://conductscience.org/library/genes/4843 | NCBI Gene |
| PTGS2 | 5,743 | PubTator's text mining | https://conductscience.org/library/genes/5743 | NCBI Gene |
1 to 10 of 11
See all 11 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32073014
GET https://conductscience.org/api/papers/v1/32073014/cited_by?page=2